Affection can stay while desire fades
Low desire can feel disconnected from an otherwise close relationship.

PT-141 · sublingual or buccal troche · coming soon
PT-141 is designed to help restore sexual desire in premenopausal women. Rebody’s needle-free troche is coming soon. Orders aren’t open yet.
Be first to know when orders open.
Product updates and occasional emails. Unsubscribe anytime.
When desire goes quiet
Low desire can feel disconnected from an otherwise close relationship.
Two phase 3 trials studied 1.75 mg subcutaneous bremelanotide in premenopausal women with HSDD.
The mini troche dissolves under the tongue or between gum and cheek.

Coming-soon strengths
Your prescription label will list the strength, directions, storage, beyond-use date, and dispensing pharmacy.
Get price and directions →What the pivotal trials measured
1,267For 24 weeks, the RECONNECT studies compared 1.75 mg subcutaneous bremelanotide with placebo. They measured change in desire and distress related to low desire.
Read the phase 3 publication ↗How the troche is taken
The mini troche dissolves in the mouth. Your prescription label will list the strength, placement, timing, maximum frequency, and flavor.
Bremelanotide injection safety
The FDA-approved injection is contraindicated in uncontrolled hypertension or known cardiovascular disease. Its label also addresses temporary blood-pressure increases, heart-rate reduction, nausea, focal hyperpigmentation, pregnancy, delayed gastric emptying, and oral naltrexone.
Read the FDA prescribing information ↗Another needle-free format
Orders are closed
We’ll email the price, directions, package, and states served.
Get the price, directions, package details, and states served.
Product updates and occasional emails. Unsubscribe anytime.